Benitec Biopharma (BNTC) Non Operating Investment Income (2019 - 2023)
Benitec Biopharma's (BNTC) quarterly Non Operating Investment Income came in at -$1000.0 in Q4 2023, up 66.67% year-on-year from -$600.0 in Q4 2022, and down 200.0% quarter-over-quarter from $1000.0 in Q2 2023.
Benitec Biopharma (BNTC) Non Operating Investment Income (2019 - 2023) Analysis & Trends
Benitec Biopharma has disclosed Non Operating Investment Income across 5 years of filings, most recently posting -$1000.0 for Q4 2023.
- Non Operating Investment Income for Q4 2023 came in at -$1000.0, up 66.67% year-over-year; the trailing twelve-month figure through Dec 2024 was -$1000.0 (up 75.0% YoY), and the FY2024 annual result was -$1000.0, up 66.67% from the prior year.
- Non Operating Investment Income came in at -$1000.0 for Q4 2023 at Benitec Biopharma, down from $1000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $19000.0 in Q2 2021 to a low of -$23000.0 in Q4 2021.
- The 5-year median for Non Operating Investment Income is -$1000.0 (2019), against an average of $71.43.
- Across the five-year window, Non Operating Investment Income plunged 2200.0% in 2021 and surged 200.0% in 2023, its largest moves.
- Benitec Biopharma's Non Operating Investment Income stood at -$1000.0 in 2019, then changed by 0.0% to -$1000.0 in 2020, then slumped by 2200.0% to -$23000.0 in 2021, then jumped by 86.96% to -$3000.0 in 2022, then jumped by 66.67% to -$1000.0 in 2023.
- The last three Non Operating Investment Income figures came in at -$1000.0 (Q4 2023), $1000.0 (Q2 2023), and -$4000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Benitec Biopharma | 488.21 Mn | 488.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | -23,000.00 |
| Dec 31, 2021 | -23,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 19,000.00 |